GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArriVent BioPharma Inc (NAS:AVBP) » Definitions » Other Assets for Insurance Companies

ArriVent BioPharma (ArriVent BioPharma) Other Assets for Insurance Companies


View and export this data going back to 2024. Start your Free Trial

What is ArriVent BioPharma Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


ArriVent BioPharma (ArriVent BioPharma) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. They seek to utilize our team's deep drug development experience to maximize the potential of our lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.